Opioid Addiction Treatment Options in Kansas

Three medicines carry most of the clinical weight in opioid use disorder care, and each one works differently on the same problem ². Understanding them helps you have a real conversation with a doctor instead of a confused one.

Buprenorphine

A partial opioid agonist. In plain terms: it binds to the same receptors that heroin, fentanyl, or oxycodone bind to, but only partly. That’s enough to shut down cravings and stop withdrawal without producing the high. You’ve probably seen it as Suboxone, a small film that dissolves under your tongue, or as a monthly extended-release injection called Sublocade. A regular family doctor, psychiatric nurse practitioner, or addiction specialist can prescribe it during an office visit — you don’t need a special clinic.

Methadone

A full opioid agonist. It fully occupies those same receptors at a steady, long-acting dose, which keeps withdrawal and cravings quiet for around 24 hours per dose. Methadone for opioid use disorder can only be dispensed through a SAMHSA-certified opioid treatment program (OTP), which is why people sometimes call it “going to the clinic” ¹³. Early on, that usually means daily visits. Kansas has loosened those rules over time, which we’ll get to.

Naltrexone

The opposite kind of medicine — an opioid antagonist. It blocks the receptors so opioids can’t attach. It comes as a daily pill or, more commonly for opioid use disorder, as Vivitrol, a monthly injection. Because it’s a blocker, you have to be fully off opioids for roughly 7 to 10 days before your first dose, or you’ll go straight into precipitated withdrawal ⁴.

Counseling and psychosocial support are meant to run alongside all three ⁴. The medicine handles the biology. The rest of the work — trauma, sleep, relationships, why you started using in the first place — needs people.

If you’re weighing your options, the real choice for most people comes down to buprenorphine versus methadone. The 2024 national clinical practice guideline update treats them as co-equal first-line treatments, not as first choice and backup ³. Both work. They just work differently, and the tradeoffs are worth knowing before you sit down with a doctor.

• Retention. A systematic review comparing the two medications found methadone is associated with higher treatment retention — meaning more people stay in care longer on methadone than on buprenorphine ⁸. That matters, because time in treatment is one of the strongest predictors of long-term recovery. If you’ve tried buprenorphine before and drifted away from it, methadone isn’t a failure step. It’s often the sturdier scaffold.

• Overdose risk. The same review found buprenorphine tends to have a lower overdose risk profile, especially once you’re through induction ⁸. Its partial-agonist ceiling means it’s harder to overdose on buprenorphine alone than on methadone at equivalent effect. That safety margin is one reason primary care clinicians can prescribe it in an office setting.

• Where you get it. Buprenorphine is office-based. Any DEA-registered clinician with Schedule III authority can write for it, so you can start it in a doctor’s office, a behavioral health clinic, or during a residential admission ¹. Methadone for OUD lives inside a certified OTP, which means dosing at a specific clinic, at least at first ¹³.

• Induction. Buprenorphine has a catch — you have to be in mild to moderate withdrawal before your first dose, or the medicine itself will trigger sudden, severe withdrawal ⁴. Methadone doesn’t have that requirement; you can start it while still comfortable, and the dose is titrated upward slowly.

• The oral naltrexone question. The 2024 guideline update also downgraded oral naltrexone, citing poor retention and no clear benefit over placebo in recent evidence ³. The monthly injection is a better bet if naltrexone is the right fit — usually for people who’ve already been off opioids for a stretch, like after a residential stay.

None of this decides itself on paper. A good clinician will listen to your history — how much you’ve been using, what you’ve tried, whether you can get to a daily clinic, whether you’re pregnant, what other medications you take — and help you pick. Both roads lead to the same place: less craving, fewer overdoses, more room to actually live your life ⁵.

If what you’ve been using is fentanyl — or something you bought that turned out to be fentanyl — the induction rules get trickier. Fentanyl is more potent than heroin and lingers in body fat longer than older opioids, which means the window where you’re in mild-to-moderate withdrawal (and ready for that first buprenorphine dose) can arrive later and feel harder to time ⁷.

Two things follow from that. First, precipitated withdrawal — the sudden, punishing kind buprenorphine can trigger if you start too early — is a real risk clinicians take seriously, and one you should hear about before your first dose ⁴. Second, patients with heavy fentanyl exposure often need higher buprenorphine doses and adjusted induction strategies than the standard protocols assumed a decade ago ⁷.

The takeaway isn’t that buprenorphine won’t work for you. It’s that you need a clinician who’s induced people off fentanyl before and who will walk you through the timing carefully. Some programs use micro-dosing induction, where small amounts of buprenorphine are layered in over days instead of hours. Ask about it. If your first attempt at induction was rough, that’s information, not a verdict.

Residential treatment means you sleep on-site, eat there, and stay for a defined stretch — at Sunflower, that’s a 60-day program. It’s the option that pulls you out of the environment you’ve been using in and gives your body and brain a chance to settle before life starts making demands again.

Here’s what the first 72 hours can look like, so it stops being a mystery.

1. Day one. You arrive. Someone takes your vitals, asks about the last time you used, and works through a medical and psychiatric history — including trauma, past treatment, and any other medications. If you’re in withdrawal or heading into it, a physician or nurse practitioner assesses you for medication. Buprenorphine induction typically begins once you’re in mild-to-moderate withdrawal, which for short-acting opioids often lands somewhere in the first 12 to 24 hours; for methadone-to-buprenorphine transitions, the wait is longer ¹¹. You’ll be checked on frequently. Sleep will be bad. That’s expected.

2. Day two. Symptoms usually peak — muscle aches, restlessness, nausea, the crawling-out-of-your-skin feeling. Medication doses get adjusted. You start meeting the people who’ll be part of your care: a therapist, a case manager, maybe a psychiatrist for co-occurring conditions ⁴.

3. Day three. The worst of the acute withdrawal begins to ease for most people on buprenorphine or methadone. You’re still tired. But you’re eating something. You’re in a room with other people who understand exactly where you’ve been. That’s when the real work — the trauma work, the group work, the sleep and the fitness and the slow rebuilding — can actually begin.

Treatment isn’t a single event you check into and check out of. It’s a stepped path, and each step is designed to hold you while giving you more of your life back.

Partial hospitalization (PHP) is the next rung down from residential. You spend most of the day in structured programming — group therapy, individual sessions, medication management, sometimes family work — and go home or to sober housing at night. It’s the level of care for someone who no longer needs 24-hour supervision but isn’t ready to be alone with a full day of unstructured time.

Intensive outpatient (IOP) steps you down further. You’re in programming several days a week for a few hours at a time, which means you can hold a job, care for kids, and sleep in your own bed while still doing serious clinical work.

Falling off usually happens at the transitions. A good program plans the handoff before you need it.

Not everyone needs — or wants — a residential stay. Kansas has two other doors into care, and knowing which one you’re walking through helps.

Office-based opioid treatment (OBOT) is what it sounds like. You see a clinician in a regular office — primary care, a psychiatric practice, a behavioral health clinic — and they prescribe buprenorphine or naltrexone. Since the federal X-waiver was removed, any DEA-registered clinician with Schedule III authority can write for buprenorphine, which has widened the pool of prescribers considerably ¹. You fill the prescription at a pharmacy like any other medication. Visits are typically weekly at first, then spaced out.

Opioid treatment programs (OTPs) are the SAMHSA-certified, DEA-registered clinics that can dispense methadone for opioid use disorder ¹⁴. If methadone is the right medicine for you, an OTP is where you go. They also dispense buprenorphine and provide required counseling and psychosocial services on-site ¹³.

Most people benefit from combining an entry point — OBOT or an OTP or a residential admission — with ongoing counseling, whether that’s IOP, individual therapy, or something like Sunflower’s PHP. The medication opens the door. What you do inside the room is what makes recovery stick.